Cargando…

Serum intact fibroblast growth factor 23 in healthy paediatric population

INTRODUCTION: It is believed that fibroblast growth factor 23 (FGF23) can become an early biomarker of chronic kidney disease progression. Data on FGF23 age dependency are inconsistent. We present the results of the cross-sectional study concerning FGF23 levels in healthy Polish children. MATERIAL A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stanczyk, Malgorzata, Chrul, Slawomir, Wyka, Krystyna, Tkaczyk, Marcin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262519/ https://www.ncbi.nlm.nih.gov/pubmed/34258392 http://dx.doi.org/10.1515/med-2021-0288

Ejemplares similares

Plasma intact fibroblast growth factor 23 levels in women with anorexia nervosa
por: Otani, Makoto, et al.
Publicado: (2008)

Intact fibroblast growth factor 23 and fragments in plasma from Gambian children
por: Braithwaite, V., et al.
Publicado: (2012)

Predictors of intact and C-terminal fibroblast growth factor 23 in Gambian children
por: Braithwaite, Vickie, et al.
Publicado: (2013)

Serum Intact Fibroblast Growth Factor 23 Levels Are Negatively Associated with Bone Mineral Density in Chronic Hemodialysis Patients
por: Lee, Wen-Teng, et al.
Publicado: (2023)

Changes in Serum Intact Fibroblast Growth Factor 23 Concentrations From Midlife to Late Life and Their Predictors in the Community: The ARIC Study
por: Ishigami, Junichi, et al.
Publicado: (2022)

Intact fibroblast growth factor 23 levels and outcome prediction in patients with acute heart failure
por: Cornelissen, Anne, et al.
Publicado: (2021)

Intact fibroblast growth factor 23 in heart failure with reduced and mildly reduced ejection fraction
por: Vergaro, Giuseppe, et al.
Publicado: (2023)

Serum microRNA profiles in patients with autosomal dominant polycystic kidney disease show systematic dysregulation partially reversible by hemodialysis
por: Małachowska, Beata, et al.
Publicado: (2019)

Linkage of Fibroblast Growth Factor 23 and Phosphate in Serum: Phosphate and Fibroblast Growth Factor 23 Reduction by Increasing Dose of Sevelamer
por: Ghorbanihaghjo, Amir, et al.
Publicado: (2018)

Lack of PTEN in osteocytes increases circulating phosphate concentrations by decreasing intact fibroblast growth factor 23 levels
por: Kawai, Masanobu, et al.
Publicado: (2020)

High intact fibroblast growth factor 23 levels associated with low hemoglobin levels in patients on chronic hemodialysis
por: Fang, Yu-Wei, et al.
Publicado: (2023)

The bone is the major source of high circulating intact fibroblast growth factor-23 in acute murine polymicrobial sepsis induced by cecum ligation puncture
por: Bayer, Jessica, et al.
Publicado: (2021)

Oral iron supplementation with sodium ferrous citrate reduces the serum intact and c‐terminal fibroblast growth factor 23 levels of maintenance haemodialysis patients
por: Yamashita, Kazuomi, et al.
Publicado: (2017)

Plasma intact fibroblast growth factor 23 levels in women with bulimia nervosa: A cross-sectional pilot study
por: Otani, Makoto, et al.
Publicado: (2011)

Fibroblast Growth Factor-23—A Potential Uremic Toxin
por: Kuczera, Piotr, et al.
Publicado: (2016)

Variation in the fibroblast growth factor 23 (FGF23) gene associates with serum FGF23 and bone strength in infants
por: Enlund-Cerullo, Maria, et al.
Publicado: (2023)

Elevated level of lysophosphatidic acid among patients with HNF1B mutations and its role in RCAD syndrome: a multiomic study
por: Małachowska, Beata, et al.
Publicado: (2022)

Intact Fibroblast Growth Factor 23 Regulates Chronic Kidney Disease–Induced Myocardial Fibrosis by Activating the Sonic Hedgehog Signaling Pathway
por: Li, Lanlan, et al.
Publicado: (2022)

Fibroblast Growth Factor 23 (FGF 23) and intact parathyroid hormone (iPTH) as markers of mineral bone disease among Nigerians with non-diabetic kidney disease
por: Raji, Yemi R, et al.
Publicado: (2022)

The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemia
por: Block, Geoffrey A, et al.
Publicado: (2019)

High C-Terminal Fibroblast Growth Factor-23, Intact Parathyroid Hormone, and Interleukin-6 as Determinants of Valvular Calcification in Regular Hemodialysis Patients
por: Kandarini, Yenny, et al.
Publicado: (2022)

Effect of Salt Intervention on Serum Levels of Fibroblast Growth Factor 23 (FGF23) in Chinese Adults: An Intervention Study
por: Hu, Jia-Wen, et al.
Publicado: (2018)

Fibroblast growth factor 23 and bone mineralisation
por: Guo, Yu-Chen, et al.
Publicado: (2015)

Physiological Actions of Fibroblast Growth Factor-23
por: Erben, Reinhold G.
Publicado: (2018)

Upstream Regulators of Fibroblast Growth Factor 23
por: Ratsma, Danielle M. A., et al.
Publicado: (2021)

Phosphate and fibroblast growth factor 23 in diabetes
por: van der Vaart, Amarens, et al.
Publicado: (2021)

Fibroblast growth factor 23, klotho and heparin
por: Thomas, S. Madison, et al.
Publicado: (2023)

Fibroblast Growth Factor 23 (FGF23) and Disorders of Phosphate Metabolism
por: Saito, Tasuku, et al.
Publicado: (2009)

PKC regulates the production of fibroblast growth factor 23 (FGF23)
por: Bär, Ludmilla, et al.
Publicado: (2019)

The Measurement and Interpretation of Fibroblast Growth Factor 23 (FGF23) Concentrations
por: Heijboer, Annemieke C., et al.
Publicado: (2022)

The Serum Level of Fibroblast Growth Factor-23 and Calcium-Phosphate Homeostasis in Obese Perimenopausal Women
por: Holecki, M., et al.
Publicado: (2011)

The stability and variability of serum and plasma fibroblast growth factor-23 levels in a haemodialysis cohort
por: Damasiewicz, Matthew J., et al.
Publicado: (2018)

Erythropoiesis stimulating agents are associated with serum fibroblast growth factor 23 metabolism in patients on hemodialysis
por: Honda, Hirokazu, et al.
Publicado: (2020)

The Clinical Spectrum of Autoimmune-Mediated Neurological Diseases in Paediatric Population
por: Lubarski, Karol, et al.
Publicado: (2022)

A Case of Hyperphosphatemia and Elevated Fibroblast Growth Factor 23: A Brief Review of Hyperphosphatemia and Fibroblast Growth Factor 23 Pathway
por: Wang, Joseph, et al.
Publicado: (2017)

Cardiac Fibroblast Growth Factor 23 Excess Does Not Induce Left Ventricular Hypertrophy in Healthy Mice
por: Leifheit-Nestler, Maren, et al.
Publicado: (2021)

Glucocorticoids dexamethasone and prednisolone suppress fibroblast growth factor 23 (FGF23)
por: Feger, Martina, et al.
Publicado: (2021)

Role of Fibroblast Growth Factor 23 (FGF23) and αKlotho in Cancer
por: Ewendt, Franz, et al.
Publicado: (2021)

Fibroblast Growth Factor 23: Potential Marker of Invisible Heart Damage in Diabetic Population
por: Kurpas, Anna, et al.
Publicado: (2023)

Fibroblast Growth Factor–23 and Cardiac Structure and Function
por: Agarwal, Isha, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8j09qeojk2nlritc93c904hfm5